News & Updates
Filter by Specialty:
Asthma control better with dupilumab-ICS combo
09 Apr 2024
byElvira Manzano
Adding the anti-interleukin-4 receptor alpha monoclonal antibody dupilumab to an inhaled corticosteroid (ICS) reduces asthma exacerbations and improves lung function in a post hoc analysis of the LIBERTY ASTHMA QUEST trial.
Asthma control better with dupilumab-ICS combo
09 Apr 2024Helping women manage menopausal symptoms can lower their health risks
08 Apr 2024
bySaras Ramiya
Menopause is defined as the end of a woman’s menstrual cycles, which is confirmed with the absence of menstruation for 12 consecutive months.